Company / FCF Margin
Kiniksa Pharmaceuticals International, plc FCF Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
20.1%
FY2025
5-year range
-419.2% / 20.1%
FY2021-FY2025
Trend
+235.5%
vs FY2024
Sector context
#30 of 133
Health Care
What the data says
FCF Margin changed +236% YoY in FY2025, a notable deviation from the 4-year average annual change of +112%.
Based on SEC 10-K filings.
20.1% in FY2025 with a 3-year CAGR of +17.5%. Top quartile in the Health Care sector.
Improved from 4.9% to 20.1% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +17.5pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Top 23% in Health CareTop 23% of 133This company 20.1% Sector average -632.8%
▼
+103.2% above sector average
Key checks
Key Insights
- Kiniksa Pharmaceuticals International, plc's fcf margin has grown for 4 consecutive years.
- In FY2025, fcf margin increased 235.5% year-over-year.
- Currently 653.0pp above the Health Care sector average.
- Lowest fcf margin in the period was in FY2021.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 20.1% | +235.5% |
| FY2024 | 6.0% | +23.2% |
| FY2023 | 4.9% | +88.0% |
| FY2022 | 2.6% | +100.6% |
| FY2021 | -419.2% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026